ITCI - intracellulartherapies.com Prognoz qilingan narxning foydaga nisbati
Klinikalar bilan strategik ittifoqlar va AQShdagi optimallashtirilgan taqsimot Intra-Cellular Therapies (ITCI) uchun Caplyta terapiyasining hamyonbopligini ta'minlaydi. Intra-Cellular Therapies (ITCI) uchun forward P/E ko'rsatkichi tartibga soluvchi siyosatning bozor qiymatiga ta'sirini namoyish etadi, 29.00 esa ushbu metrikaning joriy qiymatini ifodalaydi. Shizofreniyani davolashning etalon usullari yaratilishi ko'p yillar davomida surunkali kasalliklarni davolashda qo'llaniladigan dori vositalariga barqaror talabni kafolatlaydi.
ITCI (Intra-Cellular): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Intra-Cellular Therapies|ITCI - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Intra-Cellular Therapies Inc.|ITCI - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Intra-Cellular Therapies|Tezkor likvidlik intracellulartherapies.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ITCI - Kompaniyaning sof foydasi|Kelajakdagi foyda Intra-Cellular Therapies|ITCI - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Intra-Cellular Therapies|ITCI - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Intra-Cellular Therapies Inc.|ITCI - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Intra-Cellular Therapies|ITCI - Sirpanuvchi yil uchun bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi intracellulartherapies.com|ITCI - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Intra-Cellular Therapies
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning fundamental tahlili:Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies (ITCI) kompaniyasining psixiatrik kasalliklarni davolashdagi blokbaster mahsuloti muvaffaqiyati va uning patent himoyasi ITCI qiymatini kutilayotgan daromadlar prizmasi orqali baholash imkonini beradi. Kompaniyaning tarixiy forward P/E koeffitsiyentini tahlil qilish orqali investor joriy aksiya narxini prognoz qilingan sof foyda bilan solishtirishi mumkin, bu esa bozor narxining adolatli ekanligini va raqobat sharoitida aktivning o'sish potentsialini aniqlashga yordam beradi.
Intra-Cellular Therapies (ITCI) raqobatchilari
Kelajakdagi narxning foydaga nisbati Biogen (BIIB)|Neurocrine - Narxning kelajakdagi foydaga nisbati|Regencell - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati AXSM (Axsome Corp)|ACAD - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori XENE (xenon-pharma.com)|VKTX: Forvard P/E multiplikatori|Supernus Pharmaceuticals, Inc. (SUPN) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|DNLI - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori HRMY|Prognoz qilingan narxning foydaga nisbati biohavenpharma.com BHVN|Forvard P/E multiplikatori AMLX (Amylyx Pharmaceuticals, Inc.)|Trevi Therapeutics Inc (TRVI) - Prognoz qilingan narx-foyda nisbati|PRAX - Kelajakdagi narxning foydaga nisbati|AVXL: Kelajakdagi narxning foydaga nisbati|CeriBell, Inc. (CBLL) - Kelajakdagi narxning foydaga nisbati|PRTA (Prothena) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati ALEC|Forvard P/E multiplikatori Annexon Biosciences|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Kelajakdagi narxning foydaga nisbati NGNE (Neurogene Therapeutics)|Forvard P/E multiplikatori ACIU (AC Immune)|Forvard P/E multiplikatori voyagertherapeutics.com VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SCLX (Scilex Holding)|TVGN (Tevogen Bio Holdings, Inc.) - Prognoz qilingan narxning foydaga nisbati|Alpha Cognition Inc. - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CGTX|IKT (inhibikase.com) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori SAVA|ASRT (assertiotx.com) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Prognoz qilingan narx-foyda nisbati|OVID - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori ABOS (acumenpharm.com)|CRVO: Forvard P/E multiplikatori|Alterity Therapeutics Limited (ATHE) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Clene Inc|PepGen Corp - Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori JUNS|Kapitalizatsiyaning prognoz qilingan foydaga nisbati relmada.com|Forvard P/E multiplikatori ANVS (Annovis Bio)|Grace Therapeutics Inc (GRCE) - Prognoz qilingan narx-foyda nisbati|AIFF - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Klotho Neurosciences Inc KLTO|NRSN: Forvard P/E multiplikatori|RVPH - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati MTVA|NRXS (NeurAxis Inc.) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori HSDT|Prognoz qilingan narxning foydaga nisbati passagebio.com PASG|Forvard P/E multiplikatori NEUP (Neuphoria Therapeutics)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati minervaneurosciences.com (NERV)|ATHA - Kelajakdagi narxning foydaga nisbati|ADXN (Addex Therapeutics Ltd.) - Narxning kelajakdagi foydaga nisbati|ALZN: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Cyclerion Therapeutics, Inc. (CYCN)|Prognoz qilingan narxning foydaga nisbati PTIX|Forvard P/E multiplikatori Pasithea|Kelajakdagi narxning foydaga nisbati Cortigent, Inc. (CRGT)|ATXI (Avenue Therapeutics Inc.) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Cara Therapeutics Inc (CARA) - Prognoz qilingan narx-foyda nisbati|Chromocell Therapeutics - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Eliem Therapeutics ELYM|Longboard Pharmaceuticals, Inc. (LBPH) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati MRNS|Prognoz qilingan narxning foydaga nisbati NKGN|NRBO (NeuroBo Pharma) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Sage Therapeutics, Inc. (SAGE)|SNPX (synaptogen.com) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori TRVN (Trevena)|Forvard P/E multiplikatori Vigil Neuroscience Inc. VIGL|WENA: Prognoz qilingan narxning foydaga nisbati|Forvard narx-foyda multiplikatori Cerevel Corp (CERE)
